{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:52:18Z","timestamp":1787028738406,"version":"build-2736575974"},"reference-count":42,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T00:00:00Z","timestamp":1689465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Among the mucosal melanomas, vaginal melanomas are very rare tumors, accounting for less than 20% of melanomas arising from the female genital tract. They occur most frequently in women in post-menopausal age, but younger patients may also experience this neoplasm, mainly located in the lower third of the vagina or the anterior wall. The optimal management of this tumor remains controversial, with surgery reported as the most frequently adopted approach. However, a clear benefit of surgical treatment in terms of survival has not yet been demonstrated. Conversely, radiotherapy may represent an attractive non-invasive alternative, and there are several favorable reports of the role of radiation therapy, either delivered with photons, brachytherapy, or hadrontherapy. A wide range of techniques and fractionation regimens are reported with substantially good tolerance to the treatment, and acute G3 or higher toxicities are reported only in the case of concurrent immunotherapy. Of note, due to the rarity of the disease, there is a lack of high-level evidence for the optimal therapeutic option. In this scenario, recent studies theorize the possibility of developing combinatorial approaches of radiotherapy with immunotherapy based on cutaneous melanomas reports. In this review, we aim to summarize the evidence available in the literature supporting the role of definitive radiotherapy for vaginal melanomas, with a focus on the combination of RT with immunotherapy, in terms of optimal timing and biological rationale.<\/jats:p>","DOI":"10.3390\/jpm13071142","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:35:04Z","timestamp":1689554104000},"page":"1142","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Role of Radiotherapy in the Management of Vaginal Melanoma: A Literature Review with a Focus on the Potential Synergistic Role of Immunotherapy"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0390-9511","authenticated-orcid":false,"given":"Francesco","family":"Cuccia","sequence":"first","affiliation":[{"name":"Radiotherapy Unit, Radiation Oncology, ARNAS Civico Hospital, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8144-0168","authenticated-orcid":false,"given":"Salvatore","family":"D\u2019Alessandro","sequence":"additional","affiliation":[{"name":"Radiotherapy Unit, Radiation Oncology, ARNAS Civico Hospital, 90100 Palermo, Italy"},{"name":"Radiation Oncology School, University of Palermo, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Blasi","sequence":"additional","affiliation":[{"name":"Medical Oncology, ARNAS Civico Hospital, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Chiantera","sequence":"additional","affiliation":[{"name":"Gynecological Oncology, ARNAS Civico Hospital, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ferrera","sequence":"additional","affiliation":[{"name":"Radiotherapy Unit, Radiation Oncology, ARNAS Civico Hospital, 90100 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e232200","DOI":"10.1136\/bcr-2019-232200","article-title":"Primary malignant melanoma of the vagina","volume":"13","author":"Jamaer","year":"2020","journal-title":"BMJ Case Rep."},{"key":"ref_2","first-page":"122","article-title":"Vaginal primary malignant melanoma: Report of four cases and review of the literature","volume":"32","author":"Terzakis","year":"2011","journal-title":"Eur. J. Gynecol. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.humpath.2022.11.002","article-title":"Different clinico-pathological and prognostic features of vulvar, vaginal, and cervical melanomas","volume":"131","author":"Wu","year":"2023","journal-title":"Hum. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.2002.6848","article-title":"Mucosal melanoma of the female genital tract is a multifocal disorder","volume":"88","author":"Lotem","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.3802\/jgo.2019.30.e94","article-title":"Investigating the role of immunotherapy in advanced\/recurrent female genital tract melanoma: A preliminary experience","volume":"30","author":"Indini","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.gore.2016.04.001","article-title":"Combined immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract","volume":"16","author":"Schiavone","year":"2016","journal-title":"Gynecol. Oncol. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3389\/fonc.2019.00835","article-title":"Effect of radiotherapy combined with pembrolizumab on local tumor control in mucosal melanoma patients","volume":"9","author":"Kim","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1748-717X-6-34","article-title":"Stereotactic body radiation therapy for melanoma and renal cell carcinoma: Impact of single fraction equivalent dose on local control","volume":"6","author":"Stinauer","year":"2011","journal-title":"Radiat. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1200\/JCO.2017.76.2229","article-title":"Safety and clinical activity of pembrolizumab and multisite stereotactic body radiotherapy in patients with advanced solid tumors","volume":"36","author":"Luke","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1158\/1078-0432.CCR-19-3936","article-title":"A prospective, phase 1 trial of nivolumab, ipilimumab, and radiotherapy in patients with advanced melanoma","volume":"26","author":"Postow","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Rech","year":"2015","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S468","DOI":"10.21037\/jtd.2018.01.130","article-title":"Combining radiation plus immunotherapy to improve systemic immune response","volume":"10","author":"Cushman","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/gyno.1998.4982","article-title":"Primary malignant melanoma of the vagina: Long-term remission following radiation therapy","volume":"70","author":"Petru","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1525-1438.2007.00951.x","article-title":"Carbon ion radiotherapy for vaginal malignant melanoma: A case report","volume":"17","author":"Ohno","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.brachy.2008.04.005","article-title":"Treatment of recurrent vaginal melanoma with external beam radiation therapy and palladium-103 brachytherapy","volume":"7","author":"McGuire","year":"2008","journal-title":"Brachytherapy"},{"key":"ref_17","first-page":"20160002","article-title":"Enhanced skin toxicity with concurrent ipilimumab and radiation in vaginal\/vulvar melanoma: A case report and literature review","volume":"2","author":"Mesko","year":"2017","journal-title":"BJR Case Rep."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Murata, H., Okonogi, N., Wakatsuki, M., Kato, S., Kiyohara, H., Karasawa, K., Ohno, T., Nakano, T., Kamada, T., and Shozu, M. (2019). Long-Term Outcomes of Carbon-Ion Radiotherapy for Malignant Gynecological Melanoma. Cancers, 11.","DOI":"10.3390\/cancers11040482"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.21873\/invivo.11497","article-title":"Feasibility of Carbon Ion Radiotherapy in the Treatment of Gynecological Melanoma","volume":"33","author":"Barcellini","year":"2019","journal-title":"In Vivo"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3897\/folmed.62.e49926","article-title":"Vaginal Mucosal Melanoma: A Complete Remission after Immunotherapy and \u20180-7-21\u2019 Radiotherapy Regimen (24 Gy\/3 fractions\/21 days)","volume":"62","author":"Parisi","year":"2020","journal-title":"Folia Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ygyno.2021.03.017","article-title":"Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanoma","volume":"161","author":"Sezen","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"100839","DOI":"10.1016\/j.adro.2021.100839","article-title":"Complete Response After Stereotactic Body Radiation Therapy with Concurrent Immunotherapy for Vaginal Melanoma","volume":"7","author":"Schonewolf","year":"2021","journal-title":"Adv. Radiat. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3892\/ol.2022.13550","article-title":"Primary vaginal malignant melanoma successfully treated with combination therapy: A case report","volume":"24","author":"Yin","year":"2022","journal-title":"Oncol. Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF02524343","article-title":"Primary vaginal melanoma: A critical analysis of therapy","volume":"11","author":"Miner","year":"2004","journal-title":"Ann. Surg. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.21873\/anticanres.14260","article-title":"Outcome and Toxicity of Carbon Ion Radiotherapy for Axial Bone and Soft Tissue Sarcomas","volume":"40","author":"Cuccia","year":"2020","journal-title":"Anticancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.21873\/invivo.11944","article-title":"Re-irradiation with Carbon Ion Radiotherapy for Pelvic Rectal Cancer Recurrences in Patients Previously Irradiated to the Pelvis","volume":"34","author":"Barcellini","year":"2020","journal-title":"In Vivo"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13014-020-01544-0","article-title":"Oligometastasis and local ablation in the era of systemic targeted and immunotherapy","volume":"15","author":"Mazzola","year":"2020","journal-title":"Radiat. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"809279","DOI":"10.3389\/fonc.2022.809279","article-title":"A Novel Radiotherapeutic Approach to Treat Bulky Metastases Even From Cutaneous Squamous Cell Carcinoma: Its Rationale and a Look at the Reliability of the Linear-Quadratic Model to Explain Its Radiobiological Effects","volume":"12","author":"Ferini","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fonc.2018.00612","article-title":"Radiation, immune checkpoint blockade and the Abscopal effect: A critical review on timing. Dose and Fractionation","volume":"8","author":"Buchwald","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1667\/RR2773.1","article-title":"Radiation-induced vascular damage in tumors: Implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS)","volume":"177","author":"Park","year":"2012","journal-title":"Radiat. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11060-018-2880-y","article-title":"Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: Clinical outcomes and toxicity","volume":"139","author":"Diao","year":"2018","journal-title":"J. Neuro-Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40425-017-0282-x","article-title":"Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment","volume":"5","author":"Anderson","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.radonc.2018.02.022","article-title":"Use of extracranial radiation therapy in metastatic melanoma patients receiving immunotherapy","volume":"127","author":"Gabani","year":"2018","journal-title":"Radiother. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10585-021-10122-x","article-title":"SBRT for elderly oligometastatic patients as a feasible, safe and effective treatment opportunity","volume":"38","author":"Cuccia","year":"2021","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ctro.2017.09.002","article-title":"Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era","volume":"6","author":"Youland","year":"2017","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Stoian, A.R., Rahnea-Nita, G., Ciuhu, A.N., Gales, L., Anghel, R.M., Rebegea, L.F., Rahnea-Nita, R.A., Andronache, L.F., Soare, I., and Stoleriu, G. (2023). The Benefits and Challenges of the Multimodal Treatment in Advanced\/Metastatic Malignant Melanoma. Diagnostics, 13.","DOI":"10.3390\/diagnostics13091635"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12967-023-04089-4","article-title":"Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: Clinical evidence and mechanistic basis","volume":"21","author":"Tian","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/10781552211027348","article-title":"Spine eburnation in a metastatic lung cancer patient treated with immunotherapy and radiotherapy. The first case report of bystander effect on bone","volume":"28","author":"Parisi","year":"2022","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12967-014-0262-6","article-title":"Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: Evaluation of biomarkers of immunologic therapeutic response","volume":"12","author":"Ridolfi","year":"2014","journal-title":"J. Transl. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s40425-019-0718-6","article-title":"Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation immunotherapy","volume":"7","author":"Menon","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1158\/2326-6066.CIR-18-0793","article-title":"Phase II trial of Ipilimumab with stereotactic radiation therapy for metastatic disease: Outcomes, toxicities, and low-dose radiation-related abscopal responses","volume":"7","author":"Welsh","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41392-022-01102-y","article-title":"Radiotherapy combined with immunotherapy: The dawn of cancer treatment","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/13\/7\/1142\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:12:48Z","timestamp":1760127168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/13\/7\/1142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,16]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["jpm13071142"],"URL":"https:\/\/doi.org\/10.3390\/jpm13071142","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,16]]}}}